Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Best Practice & Research. Clinical Haematology|May 4, 2002
Minimal residual disease in acute myeloid leukaemiaJ A Liu YinLeukemia & Lymphoma|August 28, 1998
Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCRK Tobal, J A Liu YinLeukemia|September 16, 1998
RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APLK Tobal, J A Liu YinBritish Journal of Hospital Medicine|April 7, 1993
Acute tumour lysis syndromeR C Chasty, J A Liu-YinBone Marrow Transplantation|May 24, 2005
Elevated levels of WT1 transcripts in bone marrow harvests are associated with a high relapse risk in patients autografted for acute myeloid leukaemiaD Osborne, L Frost, K Tobal, et al.Clinical and Laboratory Haematology|January 1, 1987
Blood volume measurement in pseudopolycythaemia--when and why?J C Marsh, J A Liu Yin, S M LewisThe Journal of Antimicrobial Chemotherapy|August 1, 1992
A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patientsP R Johnson, J A Liu Yin, J A ToothLeukemia|July 1, 1996
Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phaseM J Saunders, K Tobal, S Keeney, et al.British Journal of Haematology|May 31, 2001
Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trialJ A Liu Yin, K Wheatley, J K Rees, et al.British Journal of Haematology|February 23, 1999
The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEGrHuMGDF) on megakaryopoiesis in patients with aplastic anaemiaM L Brereton, J A Adams, M Briggs, et al.Pageof 3